Post-Stroke Shoulder Pain Reduced with Peripheral Nerve Stimulator

Clinical results reported at the 2017 North American Neuromodulation Society meeting show that peripheral nerve stimulation can help stroke patients. And that peripheral nerve stimulation provides meaningful relief for people suffering from post-stroke shoulder pain (PSSP). Post stroke shoulder pain is experienced by anywhere between 30 and 70 percent of stroke sufferers. Dr. Porter McRoberts is a trained Physiatrist and Interventional Spine and Pain Management Specialist in Fort Lauderdale, Florida. He shared data indicating that peripheral nerve stimulation is a promising treatment for post-stroke shoulder pain (PSSP) patients. When compared to the alternative options for pain management, it proved helpful.…
Read More

Sacral Neuromodulation for Sacrectomy Patients

Sacral chordoma is a rare malignant tumor arising from remnants of the notochord. Due to its propensity for recurrence, the treatment of choice is surgical resection. Orthopedic and neurosurgical literature describe bladder dysfunction as prevalent in these patients, specifically urinary incontinence, however urologic literature is lacking in the exact nature of this dysfunction. Thus far, Sacral Nerve Stimulation (SNS) has not been described as a treatment option for these patients. We describe a 36-year-old female who underwent midsacral resection (S3 and below) for a sacrococcygeal chordoma. She suffered from postoperative urinary incontinence and incomplete emptying requiring intermittent catheterization. Urodynamic evaluation…
Read More

Peripheral Nerve Stimulation Reduces Chronic Headaches

Peripheral nerve stimulation (PNS) is an effective long-term treatment for managing chronic intractable headaches, suggests research published in Pain Physician. In this retrospective study, peripheral nerve stimulation reduced mean headache severity on the 11-point Numeric Rating Schedule (NRS) by nearly 50% within one-month post implantation. After 12 months, headache severity scores decreased by at least 50% in 87% (40 of 46) of the patients, with pain decreasing even more substantially the longer the device was in place. Pain intensity scores on the NRS had decreased by 68% as many as 98 months post-implantation. These findings were consistent with previous studies; however,…
Read More

Electrical Nerve Stimulation Device Prevents Migraine

Study shows 81% reduction in number of migraine days per month with electrical nerve stimulation In a new study, Cefaly, the first FDA-approved transcutaneous electrical nerve-stimulation device for use before onset of migraine pain. It was shown to have provided relief for 81% of migraine patients who used it. The study, conducted in Italy, enrolled 24 patients with migraine without aura. These patients were experiencing a low number of attacks per month and who had taken migraine-preventive drugs. The primary outcome measures were the reductions in migraine attacks and in the number of migraine days per month. Then investigators also…
Read More